Anjali Sharma1, Peter L Flom2, Clifford J Rosen3, Ellie E Schoenbaum4. 1. Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: anjali.sharma@einstein.yu.edu. 2. Peter Flom Consulting, New York, NY, USA. 3. Department of Medicine, Maine Medical Center Research Institute, Scarborough, ME, USA. 4. Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA; Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, Bronx, NY, USA.
Abstract
OBJECTIVE: To characterize changes in bone mineral density (BMD) according to race among HIV-infected and uninfected women, and to evaluate the relationship between race and menopause-related bone loss. METHODS: Dual X-ray absorptiometry measured BMD on study entry and a minimum of 18 months later in 246 HIV-infected and 219 HIV-uninfected women in the Menopause Study. Linear regression analyses determined percent annual BMD change at the total hip (TH), femoral neck (FN), and lumbar spine (LS) after adjusting for potential confounders. Race-stratified and HIV-infected subgroup analyses were performed. RESULTS: At baseline, mean age was 45 years, 19% of women were postmenopausal. HIV-infected women were more likely to be black (58% vs. 38%), and had lower BMI and less cigarette exposure when compared to HIV-uninfected women. Women who were perimenopausal at baseline and postmenopausal at follow-up had the greatest TH bone loss (-1.68%/yr, p < .0001) followed by those postmenopausal throughout (-1.02%/yr, p = .007). We found a significant interaction between HIV status and race in multivariate analyses of BMD change at the FN and TH. In race-stratified analyses, HIV infection was associated with TH BMD loss in non-black women. Black women experienced greater menopause-associated decline in TH BMD compared with non-black women. CONCLUSIONS: The association of HIV and BMD differs strikingly by race, as do the effects of the menopausal transition on bone. Determining the extent to which the effect of HIV on fracture risk varies by race will be crucial to identify HIV-infected women at greatest risk for osteoporotic fracture, particularly as they enter menopause.
OBJECTIVE: To characterize changes in bone mineral density (BMD) according to race among HIV-infected and uninfected women, and to evaluate the relationship between race and menopause-related bone loss. METHODS: Dual X-ray absorptiometry measured BMD on study entry and a minimum of 18 months later in 246 HIV-infected and 219 HIV-uninfectedwomen in the Menopause Study. Linear regression analyses determined percent annual BMD change at the total hip (TH), femoral neck (FN), and lumbar spine (LS) after adjusting for potential confounders. Race-stratified and HIV-infected subgroup analyses were performed. RESULTS: At baseline, mean age was 45 years, 19% of women were postmenopausal. HIV-infectedwomen were more likely to be black (58% vs. 38%), and had lower BMI and less cigarette exposure when compared to HIV-uninfectedwomen. Women who were perimenopausal at baseline and postmenopausal at follow-up had the greatest TH bone loss (-1.68%/yr, p < .0001) followed by those postmenopausal throughout (-1.02%/yr, p = .007). We found a significant interaction between HIV status and race in multivariate analyses of BMD change at the FN and TH. In race-stratified analyses, HIV infection was associated with TH BMD loss in non-black women. Black women experienced greater menopause-associated decline in TH BMD compared with non-black women. CONCLUSIONS: The association of HIV and BMD differs strikingly by race, as do the effects of the menopausal transition on bone. Determining the extent to which the effect of HIV on fracture risk varies by race will be crucial to identify HIV-infectedwomen at greatest risk for osteoporotic fracture, particularly as they enter menopause.
Authors: Samantha A Miller; Nanette Santoro; Yungtai Lo; Andrea A Howard; Julia H Arnsten; Michelle Floris-Moore; Galina Moskaleva; Ellie E Schoenbaum Journal: Menopause Date: 2005 May-Jun Impact factor: 2.953
Authors: Sara E Dolan; Jeannie S Huang; Kathleen M Killilea; Meghan P Sullivan; Negar Aliabadi; Steven Grinspoon Journal: AIDS Date: 2004-02-20 Impact factor: 4.177
Authors: Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Nanette Santoro; Ellie E Schoenbaum Journal: Clin Infect Dis Date: 2006-02-24 Impact factor: 9.079
Authors: Christie G Turin; Naveed Khanjee; Katharine Breaux; Reina Armamento-Villareal; Maria C Rodriguez-Barradas; Eva H Clark Journal: AIDS Res Hum Retroviruses Date: 2022-01-24 Impact factor: 1.723
Authors: Anna Hachfeld; Andrew Atkinson; Petra Stute; Alexandra Calmy; Philip E Tarr; Katharine Darling; Baharak Babouee Flury; Christian Polli; Leila Sultan-Beyer; Irene A Abela; Karoline Aebi-Popp Journal: HIV Med Date: 2022-02-22 Impact factor: 3.094